Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
Top Cited Papers
Open Access
- 18 August 2015
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 314 (7), 687-699
- https://doi.org/10.1001/jama.2015.9676
Abstract
Obesity is a chronic disease1 and a significant global health challenge.2 Its associated comorbidities include cardiovascular morbidity and mortality,3 type 2 diabetes, certain cancers, dyslipidemia, and obstructive sleep apnea.4 Moreover, obesity reduces health-related quality of life.5Keywords
This publication has 24 references indexed in Scilit:
- Myocardial Infarction and Ischemic Heart Disease in Overweight and Obesity With and Without Metabolic SyndromeJAMA Internal Medicine, 2014
- Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adultsInternational Journal of Obesity, 2013
- Long-Term Persistence of Hormonal Adaptations to Weight LossThe New England Journal of Medicine, 2011
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2010
- The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1–5 studiesDiabetes, Obesity and Metabolism, 2009
- The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysisBMC Public Health, 2009
- Global burden of obesity in 2005 and projections to 2030International Journal of Obesity, 2008
- The Effects of Pharmacologic Agents for Type 2 Diabetes Mellitus on Body WeightPostgraduate Medicine, 2008
- The impact of obesity on health-related quality-of-life in the general adult US populationPublished by Oxford University Press (OUP) ,2005
- The Prevention and Treatment of Obesity: Application to type 2 diabetesDiabetes Care, 1997